Emergence and phenotypic characterization of the global sars-cov-2 c.1.2 lineage

HIGHLIGHTS

• who: Cathrine Scheepers from the Samples and ethics approvalsSARS-Co, genomic surveillance: As part of monitoring viral evolution by the Network for Genomics Surveillance of South Africa (NGS-SA)5, seven sequencing hubs receive randomly selected samples for sequencing every week according to approved protocols at each site. These samples include remnant nucleic acid extracts or remnant nasopharyngeal and oropharyngeal swab samples from routine diagnostic SARS-Co, PCR testing, from public and private laboratories in South Africa. Permission was obtained for associated metadata for the samples including date and location (district and province) of sampling, and sex . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.